ConductScience.org, home

Paper12912922

Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein.

Na X and 7 others. EMBO J, 2003. Cited by 81 papers, by iCite.

Cite this record

ConductScience Library. Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein. Papers, record 12912922. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12912922

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein.
PubMed
Journal
EMBO J
PubMed
Year
2003
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
81
iCite
Relative citation ratio, by iCite
1.2
iCite
Revised in PubMed
2024-11-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Na XXi
2Duan HOHai Ou
3Messing EMEdward M
4Schoen SRSusan R
5Ryan CKCharlotte K
6di Sant'Agnese PAP Anthony
7Golemis EAErica A
8Wu GGuan

Source PubMed

Download CSV of authors

Topics26

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Protein SubunitsMajor topic
ProteinsMajor topic
RNA Polymerase IIMajor topic
von Hippel-Lindau DiseaseMajor topic
Cell Nucleus
Cysteine Endopeptidases
Endothelial Growth Factors
Gene Expression Regulation, Neoplastic
HeLa Cells
Humans
Intercellular Signaling Peptides and Proteins
Kidney Neoplasms
Lymphokines
Multienzyme Complexes
Mutation
Promoter Regions, Genetic
Proteasome Endopeptidase Complex
Protein Isoforms
Protein Structure, Tertiary
RNA, Messenger
Transcriptional Activation
Transfection
Tumor Cells, Cultured
Ubiquitins
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA006927NCI NIH HHSUnited StatesP01CA006927PubMed and NIHNIH RePORTER
CA-06927NCI NIH HHSUnited StatesP01CA006927PubMed and NIHNIH RePORTER
P30CA006927NIHNIH RePORTER

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110353251The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.Nature1999https://conductscience.org/library/papers/10353251PubMed
29829926Rpb4, a subunit of RNA polymerase II, enables the enzyme to transcribe at temperature extremes in vitro.J Bacteriol1998https://conductscience.org/library/papers/9829926PubMed
310082533Rpb7 can interact with RNA polymerase II and support transcription during some stresses independently of Rpb4.Mol Cell Biol1999https://conductscience.org/library/papers/10082533PubMed
410878807Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein.Nat Cell Biol2000https://conductscience.org/library/papers/10878807PubMed
510535940Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10535940PubMed
69528765Analysis of the interaction of the novel RNA polymerase II (pol II) subunit hsRPB4 with its partner hsRPB7 and with pol II.Mol Cell Biol1998https://conductscience.org/library/papers/9528765PubMed
711431362Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.Cancer Res2001https://conductscience.org/library/papers/11431362PubMed
810784442Architecture of RNA polymerase II and implications for the transcription mechanism.Science2000https://conductscience.org/library/papers/10784442PubMed
98407810A growth rate-limiting process in the last growth phase of the yeast life cycle involves RPB4, a subunit of RNA polymerase II.J Bacteriol1993https://conductscience.org/library/papers/8407810PubMed
1010973499Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/10973499PubMed
117579693Human RNA polymerase II subunit hsRPB7 functions in yeast and influences stress survival and cell morphology.Mol Biol Cell1995https://conductscience.org/library/papers/7579693PubMed
1210944113Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.EMBO J2000https://conductscience.org/library/papers/10944113PubMed
139829911Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.Hum Mutat1998https://conductscience.org/library/papers/9829911PubMed
149545247Structure of wild-type yeast RNA polymerase II and location of Rpb4 and Rpb7.EMBO J1998https://conductscience.org/library/papers/9545247PubMed
1512019178Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.Cancer Res2002https://conductscience.org/library/papers/12019178PubMed
1610823831Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.J Biol Chem2000https://conductscience.org/library/papers/10823831PubMed
1710213691Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase.Science1999https://conductscience.org/library/papers/10213691PubMed
1811292862HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.Science2001https://conductscience.org/library/papers/11292862PubMed
198488730RPB7, one of two dissociable subunits of yeast RNA polymerase II, is essential for cell viability.Yeast1993https://conductscience.org/library/papers/8488730PubMed
208187067Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.Cancer Res1994https://conductscience.org/library/papers/8187067PubMed

See all 39 referencesDownload CSV of references

Cited by50

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.

PMIDTitleJournalYearIn PapersSource
42593521Recent advances in etiology and treatment of von Hippel-Lindau Disease (VHLD).Cancer Metastasis Rev2026https://conductscience.org/library/papers/42593521PubMed
41372667Dysregulation of the ubiquitin-proteasome system in von Hippel-Lindau syndrome: molecular insights and clinical perspectives.Clin Exp Med2025https://conductscience.org/library/papers/41372667PubMed
39738247SOCS domain targets ECM assembly in lung fibroblasts and experimental lung fibrosis.Sci Rep2024https://conductscience.org/library/papers/39738247PubMed
38225631ARMC5 controls the degradation of most Pol II subunits, and ARMC5 mutation increases neural tube defect risks in mice and humans.Genome Biol2024https://conductscience.org/library/papers/38225631PubMed
38010567A multi-model based on radiogenomics and deep learning techniques associated with histological grade and survival in clear cell renal cell carcinoma.Insights Imaging2023https://conductscience.org/library/papers/38010567PubMed
37969742Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy.Acta Pharm Sin B2023https://conductscience.org/library/papers/37969742PubMed
35535400
Heterogeneous nuclear ribonucleoprotein U-actin complex derived from extracellular vesicles facilitates proliferation and migration of human coronary artery endothelial cells by promoting RNA polymerase II transcription.
Bioengineered2022https://conductscience.org/library/papers/35535400PubMed
35205407The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis.Genes (Basel)2022https://conductscience.org/library/papers/35205407PubMed
34376376Von Hippel-Lindau tumor suppressor pathways & corresponding therapeutics in kidney cancer.J Genet Genomics2021https://conductscience.org/library/papers/34376376PubMed
33504946Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2Prame complex.Cell Death Differ2021https://conductscience.org/library/papers/33504946PubMed
33142830Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression.Int J Mol Sci2020https://conductscience.org/library/papers/33142830PubMed
32947307The von Hippel-Lindau Tumor Suppressor Gene: Implications and Therapeutic Opportunities.Cancer J2020https://conductscience.org/library/papers/32947307PubMed
32621419[Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery].Zhejiang Da Xue Xue Bao Yi Xue Ban2020https://conductscience.org/library/papers/32621419PubMed
32603638The pVHL neglected functions, a tale of hypoxia-dependent and -independent regulations in cancer.Open Biol2020https://conductscience.org/library/papers/32603638PubMed
32339495Understanding the Oxygen-Sensing Pathway and Its Therapeutic Implications in Diseases.Am J Pathol2020https://conductscience.org/library/papers/32339495PubMed
30943211Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors.PLoS Comput Biol2019https://conductscience.org/library/papers/30943211PubMed
30518623Bexarotene - a novel modulator of AURKA and the primary cilium in VHL-deficient cells.J Cell Sci2018https://conductscience.org/library/papers/30518623PubMed
30444862Functional Long Noncoding RNAs (lncRNAs) in Clear Cell Kidney Carcinoma Revealed by Reconstruction and Comprehensive Analysis of the lncRNA-miRNA-mRNA Regulatory Network.Med Sci Monit2018https://conductscience.org/library/papers/30444862PubMed
29562667VHL and Hypoxia Signaling: Beyond HIF in Cancer.Biomedicines2018https://conductscience.org/library/papers/29562667PubMed
28775317Interaction between von Hippel-Lindau Protein and Fatty Acid Synthase Modulates Hypoxia Target Gene Expression.Sci Rep2017https://conductscience.org/library/papers/28775317PubMed

See all 50 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
POLR2G5436PubTator's text mininghttps://conductscience.org/library/genes/5436NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene
VHL7428PubTator's text mininghttps://conductscience.org/library/genes/7428NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12912922

GET https://conductscience.org/api/papers/v1/12912922/references?page=2